Sunshine Biopharma, Inc. SBFM
Set alert
At close · Oct 30
After hours · Oct 30, 7:57 PM ET
- YTD
- -98.81%
- 1 year
- -99.16%
- Open
- 3.10
- Prev close
- 3.33
- Mkt cap
- 2.23M
- Vol
- 113.99K
- Avg vol
- 302.45K
- EPS
- -189.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.65
- High
- 3.21
- Forward P/E
- 0.02
- Beta
- -1.04
- Short ratio
- 0.39
- Inst. own
- 1.84%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.80
- 200-d avg
- 25.68
- 1y target
- 300.00
News
1 week ago accessnewswire.com
Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing
FORT LAUDERDALE, FL / ACCESS Newswire / October 22, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company specializing in generic and specialty prescription…
2 weeks ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Regencell Bioscience (NASDAQ:RGC) stock increased by 30.4% to $10.58 during Thursday's regular session. The company's market cap stands at $4.0 billion. SenesTech (NASDAQ:SNES) stock rose…
2 weeks ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Alaunos Therapeutics (NASDAQ:TCRT) stock moved upwards by 203.8% to $3.19 during Tuesday's regular session. The company's market cap stands at $2.6 million. Picard Medical (AMEX:PMI) stock…
2 weeks ago defenseworld.net
Sunshine Biopharma, Inc. (NASDAQ:SBFM) Sees Significant Growth in Short Interest
Sunshine Biopharma, Inc. (NASDAQ: SBFM - Get Free Report) saw a significant increase in short interest during the month of September. As of September 30th, there was short interest totaling 131,478…
3 weeks ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Quantum-Si (NASDAQ:QSI) stock rose 30.3% to $1.59 during Friday's regular session. The company's market cap stands at $267.0 million. Nautilus Biotechnology (NASDAQ:NAUT) stock rose 26.09% to…
3 weeks ago accessnewswire.com
Sunshine Biopharma Announces Closing of up to $20.4 Million Public Offering
$6.0 million upfront with an additional $14.4 million of potential aggregate gross proceeds upon the exercise of warrants FORT LAUDERDALE, FL / ACCESS Newswire / October 9, 2026 / Sunshine Biopharma…
-
3 weeks ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Pacira BioSciences (NASDAQ:PCRX) shares moved upwards by 44.0% to $36.3 during Thursday's regular session. The company's market cap stands at $1.0 billion. Onconetix (NASDAQ:ONCO) stock rose…
3 weeks ago benzinga.com
Crude Oil Gains 5%; PepsiCo Posts Upbeat Q3 Earnings
U.S. stocks fell Thursday as Nasdaq slid 150+ points; energy rallied, healthcare dropped. PepsiCo beat estimates but cut FY26 outlook; oil jumped 5%.
3 weeks ago benzinga.com
Dow Falls Over 100 Points; US Initial Jobless Claims Decline
U.S. stocks fell Thursday, led by tech, while energy rose and oil jumped 4.8%. Jobless claims eased to 197,000; small caps posted sharp swings.
-
3 weeks ago benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Profound Medical (NASDAQ:PROF) shares moved upwards by 21.5% to $6.9 during Thursday's pre-market session. The company's market cap stands at $207.5 million. Haemonetics (NYSE:HAE) stock…
3 weeks ago accessnewswire.com
Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering
FORT LAUDERDALE, FL / ACCESS Newswire / October 8, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company specializing in generic and specialty prescription…
-
3 weeks ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers China SXT Pharmaceuticals (NASDAQ:SXTC) shares increased by 186.0% to $3.58 during Wednesday's regular session. Sunshine Biopharma (NASDAQ:SBFM) stock moved upwards by 151.31% to $1.0. The…
-
3 weeks ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers China SXT Pharmaceuticals (NASDAQ:SXTC) shares moved upwards by 64.0% to $2.05 during Tuesday's after-market session. The market value of their outstanding shares is at $1.1 million. Neogen…
-
3 weeks ago benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers HeartBeam (NASDAQ:BEAT) stock moved upwards by 70.5% to $0.74 during Monday's regular session. The market value of their outstanding shares is at $24.4 million. PDS Biotechnology…
3 weeks ago benzinga.com
US Stocks Mixed; Nasdaq Gains Over 50 Points
U.S. stocks mixed: Nasdaq and S&P 500 rose while Dow dipped. Weak jobs data pressured outlook; oil fell, while gold, silver and copper gained.
-
3 weeks ago benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Apimeds Pharmaceuticals (AMEX:APUS) stock moved upwards by 76.7% to $5.69 during Monday's pre-market session. The market value of their outstanding shares is at $4.8 million. Alector…
-
1 month ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Elutia (NASDAQ:ELUT) stock moved upwards by 17.2% to $0.94 during Thursday's after-market session. The market value of their outstanding shares is at $34.9 million. Intelligent Bio Solutions…
-
1 month ago benzinga.com
Sunshine Biopharma Amends Articles Of Incorporation To Allow For Reverse Stock Split Of Up To 1-For-20; Board Of Directors Has Discretion To Effect The Split
On September 15, 2026, the Company received written consent in lieu of a meeting of stockholders from Dr. Steve N. Slilaty, our Chief Executive Officer, the holder of approximately 97% of the total…
1 month ago zacks.com
Sunshine Biopharma, Inc. (SBFM) Upgraded to Buy: Here's What You Should Know
Sunshine Biopharma, Inc. (SBFM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
-
1 month ago benzinga.com
Sunshine Biopharma Launches Generic Ondansetron Tablets Of 4mg And 8mg In Canadian Market
Launch introduces ondansetron 4 mg and 8 mg tablets for nausea and vomiting associated with chemotherapy, radiation therapy and surgeryGlobal ondansetron market projected to reach $2.98 billion by…
1 month ago accessnewswire.com
Sunshine Biopharma Launches Generic Zofran(R) in Canada, Expanding Oncology Supportive Care Portfolio
Launch introduces ondansetron 4 mg and 8 mg tablets for nausea and vomiting associated with chemotherapy, radiation therapy and surgery Global ondansetron market projected to reach $2.98 billion by…
-
1 month ago benzinga.com
Sunshine Biopharma Says CEO Steve Slilaty, Holder Of About 97% Of Voting Power, Approved Reverse Stock Split Of Up To 1-For-20 By Written Consent
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001402328/000168316826007193/sunshine_8k.htmhttps://www.sec.gov/Archives/edgar/data/1402328/000168316826007195/sunshine_pre14c.htm
1 month ago accessnewswire.com
Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies
Nanomolar potency against PLpro with broad-spectrum SARS-CoV-2 variants activity Significant dose-dependent suppression of pulmonary viral replication in vivo Strong oral bioavailability and…
1 month ago benzinga.com
EXCLUSIVE: Sunshine Biopharma Advances 'Differentiated Antiviral Candidate' to IND-Enabling Studies
Sunshine Biopharma advances its lead coronavirus drug candidate into IND-enabling studies after strong preclinical results in animal models.
-
2 months ago benzinga.com
Sunshine Biopharma Announces Approval Of Atenolol Tablets Of 25mg, 50mg And 100mg For Canadian Market
Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medications, is pleased to announce the approval of its…
2 months ago accessnewswire.com
Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions
FORT LAUDERDALE, FL / ACCESS Newswire / August 31, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription…
-
2 months ago benzinga.com
Sunshine Biopharma Announces Updates On Its K1.1 mRNA Tumor Suppressor; Outlines Plans For Program
Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company offering and researching life-saving medicines across multiple therapeutic areas including oncology and…
2 months ago accessnewswire.com
Sunshine Biopharma Reports In Vivo Tumor Suppression with K1.1 mRNA and Advances Novel mRNA-Cancer Vaccine Strategy for Lung Cancer
K1.1 mRNA demonstrated tumor-suppressing activity as a single agent in multiple in vivo hepatocellular carcinoma models Program targets a tumor suppressor frequently mutated in difficult-to-treat…
2 months ago benzinga.com
EXCLUSIVE: Sunshine Biopharma Advances Vaccine Strategy for Lung Cancer
Sunshine Biopharma outlines K1.1 mRNA pipeline updates, advancing dual oncology therapy to target cold tumors in liver and lung cancer.
-
2 months ago benzinga.com
Sunshine Biopharma Announces Approval Of Generic Enalapril Tablets 2.5mg, 5mg, 10mg And 20mg For Canadian Market
Global anti-hypertensive drug market projected to reach $37.24 billion by 2034Enalapril is a widely prescribed ACE inhibitor used to treat hypertension, heart failure and left ventricular…
2 months ago accessnewswire.com
Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market
Global anti-hypertensive drug market projected to reach $37.24 billion by 2034 Enalapril is a widely prescribed ACE inhibitor used to treat hypertension, heart failure and left ventricular…
2 months ago benzinga.com
EXCLUSIVE: Sunshine Biopharma Secures Canadian Approval for Generic Hypertension Drug
Sunshine Biopharma secures Canadian regulatory approval for generic Enalapril tablets to treat high blood pressure by 2026.
2 months ago accessnewswire.com
Sunshine Biopharma Launches Amoxicillin in Canada and Begins Pharmacy Shipments, Targeting an Estimated $4.9 Billion Global Market
Sunshine Biopharma's Amoxicillin now shipping to Canadian pharmacies in multiple dosages and strengths Launch expands Sunshine Biopharma's growing portfolio of essential prescription medications…
2 months ago accessnewswire.com
Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval
Dienogest is first-line therapy for pelvic pain associate with endometriosis The endometriosis treatment market is projected to reach $5.2 billion by 2034 FORT LAUDERDALE, FL / ACCESS Newswire /…
2 months ago benzinga.com
EXCLUSIVE: Sunshine Biopharma Targets Canadian Market with New Women's Health Drug Approval
Pharmaceutical firm Sunshine Biopharma Inc. (NASDAQ:SBFM) on Tuesday said it received regulatory approval to introduce its 2mg generic Dienogest tablets to the Canadian market.
2 months ago benzinga.com
EXCLUSIVE: Sunshine Biopharma Targets Canadian Market with New Women's Health Drug Approval
Sunshine Biopharma secures Canadian approval for its generic 2mg Dienogest tablets, expanding into women's health.
3 months ago defenseworld.net
Reviewing Foghorn Therapeutics (NASDAQ:FHTX) and Sunshine Biopharma (NASDAQ:SBFM)
Sunshine Biopharma (NASDAQ: SBFM - Get Free Report) and Foghorn Therapeutics (NASDAQ: FHTX - Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare…
3 months ago accessnewswire.com
Health Canada Approves Sunshine Biopharma's Ondansetron for Treatment of Chemotherapy-Induced Nausea and Vomiting
FORT LAUDERDALE, FL / ACCESS Newswire / July 28, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription…
-
3 months ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Shuttle Pharmaceuticals (NASDAQ:SHPH) shares moved upwards by 25.1% to $3.79 during Monday's after-market session. The company's market cap stands at $1.8 million. China Pharma Holding…
3 months ago accessnewswire.com
Sunshine Biopharma and University of Arizona Publish Significant New Research Findings
FORT LAUDERDALE, FL / ACCESS Newswire / July 20, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription…
3 months ago defenseworld.net
Sunshine Biopharma, Inc. (NASDAQ:SBFM) Short Interest Down 35.0% in June
Sunshine Biopharma, Inc. (NASDAQ: SBFM - Get Free Report) saw a significant drop in short interest in the month of June. As of June 30th, there was short interest totaling 113,463 shares, a drop of…
-
4 months ago benzinga.com
Sunshine Biopharma Announces Approval Of Generic Anastrozole Tablets Of 1mg For Canadian Market
Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medications, is pleased to announce the approval of its…
4 months ago accessnewswire.com
Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Arimidex(R)
FORT LAUDERDALE, FL / ACCESS Newswire / June 25, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription…
5 months ago benzinga.com
Why Hewlett Packard Enterprise Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket
HPE stock jumps 26.55% after reporting strong revenue growth. Top gainers are DXST, MRVL and more. Top losers are FULC, JZ, and more.
-
5 months ago benzinga.com
Sunshine Biopharma Receives Canada Approval For Its Generic Rivaroxaban Tablets
Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medications, is pleased to announce the approval of its…
5 months ago accessnewswire.com
Sunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R)
FORT LAUDERDALE, FL / ACCESS Newswire / June 1, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription…
5 months ago accessnewswire.com
Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment Technology
FORT LAUDERDALE, FL / ACCESS Newswire / May 29, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription…
5 months ago benzinga.com
Why Sunshine Biopharma (SBFM) Stock Dropped After Hours Today
Sunshine Biopharma stock fell after hours after the company announced a 1-for-10 reverse stock split to maintain Nasdaq listing compliance.
5 months ago benzinga.com
Dow Jumps Around 200 Points; Best Buy Posts Upbeat Q1 Results
U.S. stocks rise, Dow Jones gains 200 points. NASDAQ up 0.73%, S&P 500 up 0.56%. Health care shares jump 1.4%, financial stocks fall 0.5%. Best Buy beats expectations. 3 E Network Technology Group…
-
5 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session